Related Experiment Video
Updated: Aug 26, 2026

The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling
J H M van Delft1, E van Agen, S G J van Breda
1Department of Health Risk Analysis and Toxicology, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands. j.vandelft@grat.unimaas.nl
Abstract:
Two general mechanisms are implicated in chemical carcinogenesis. The first involves direct damage to DNA, referred to as genotoxic (GTX), to which the cell responds by repair of the damages, arrest of the cell cycle or induction of apoptosis. The second is non-DNA damaging, non-genotoxic (NGTX), in which a wide variety of cellular processes may be involved. Therefore, it can be hypothesized that modulation of the underlying gene expression patterns is profoundly distinct between GTX and NGTX carcinogens, and thus that expression profiling is applicable for classification of chemical carcinogens as GTX or NGTX. We investigated this hypothesis by analysing modulation of gene expression profiles induced by 20 chemical carcinogens in HepG2 cells with application of cDNA microarrays that contain 597 toxicologically relevant genes. In total, 22 treatments were included, divided in two sets. The training set consisted of 16 treatments (nine genotoxins and seven non-genotoxins) and the validation set of six treatments (three and three). Class discrimination models based on Pearson correlation analyses for the 20 most discriminating genes were developed with data from the training set, where after the models were tested with all data. Using all data, the correctness for classification of the carcinogens from the training set was clearly better than that for the validation set, namely 81 and 33%, respectively. Exclusion of the treatments that had only marginal effects on the expression profiles, improved the discrimination for the training and validation sets to 92 and 100% correctness, respectively. Exclusion of the gene expression signals that were hardly altered also improved classification, namely to 94 and 80%. Therefore, our study proves the principle that gene expression profiling can discriminate carcinogens with major differences in their mode of actions, namely genotoxins versus non-genotoxins.
Insights
Gene expression profiling can distinguish between genotoxic (DNA-damaging) and non-genotoxic (non-DNA-damaging) carcinogens. This method shows promise for classifying chemical carcinogens based on their distinct mechanisms of action.
Area of Science:
- Toxicology
- Molecular Biology
- Genetics
Background:
- Chemical carcinogenesis involves two main mechanisms: genotoxic (DNA-damaging) and non-genotoxic (non-DNA-damaging).
- These distinct mechanisms are hypothesized to result in different gene expression patterns.
Purpose of the Study:
- To investigate if gene expression profiling can classify chemical carcinogens as genotoxic or non-genotoxic.
- To assess the applicability of expression profiling for distinguishing between different modes of carcinogenic action.
Main Methods:
- Analysis of gene expression profiles in HepG2 cells treated with 20 chemical carcinogens using cDNA microarrays.
- Development and testing of classification models based on Pearson correlation of the 20 most discriminating genes.
- Data analysis included training and validation sets, with iterative refinement by excluding marginal effects.
Main Results:
- Initial classification accuracy was 81% for the training set and 33% for the validation set.
- Excluding treatments with marginal effects improved discrimination to 92% (training) and 100% (validation).
- Further exclusion of minimally altered gene expression signals yielded 94% (training) and 80% (validation) accuracy.
Conclusions:
- Gene expression profiling effectively discriminates between genotoxic and non-genotoxic carcinogens.
- This approach demonstrates the principle of classifying carcinogens based on their distinct molecular mechanisms.
- Expression profiling is a viable tool for understanding and categorizing chemical carcinogen actions.
Related Concept Videos
Mutagenicity and Carcinogenicity
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
In-vitro Mutagenesis (Gene Knockouts)
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
